Goldman Sachs Group »

Mink Therapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Mink Therapeutics (INKT) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Mink Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mink Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mink Therapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $22k 20k 1.07
2023-09-30 $19k 17k 1.10
2023-06-30 $36k 17k 2.10